ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,322.80
0.00%
S&P ASX All Technology
4,098.90
0.00%
Brent Oil
76.155
0.44%
US Dollar vs AUD
1.56196
-0.97%
Bitcoin
98,446.27
1.88%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Terns Pharmaceuticals Inc (TERN) Share Price

Terns Pharmaceuticals Inc

Terns Pharmaceuticals Inc (TERN)

Tern Plc
4.175
-0.015
( -0.36% )
Updated: 07:01:30
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
4.175
Bid
4.17
Offer
4.18
Volume
614,172
4.08 Day's Range 4.24
4.005 52 Week Range 11.40
Market Cap
354.62M
Previous Close
4.19
Open
4.142
Last Trade
10
@
4.175
Last Trade Time
07:02:22
Financial Volume
US$ 2,569,906
VWAP
4.1843
Average Volume (3m)
1,838,574
Shares Outstanding
84,938,855
Dividend Yield
-
PE Ratio
-3.93
Earnings Per Share (EPS)
-1.06
Revenue
-
Net Profit
-90.21M

About Terns Pharmaceuticals Inc

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.ternspharma.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Terns Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TERN. The last closing price for Terns Pharmaceuticals was US$4.19. Over the last year, Terns Pharmaceuticals shares have traded in a share price range of US$ 4.005 to US$ 11.40.

Terns Pharmaceuticals currently has 84,938,855 shares in issue. The market capitalisation of Terns Pharmaceuticals is US$355.89 million. Terns Pharmaceuticals has a price to earnings ratio (PE ratio) of -3.93.

Ask ADVFN Intelligence (AI)

Terns Pharmaceuticals (TERN) Options Flow Summary

TERN Options Flow

Overall Flow

Bearish

Net Premium

-60k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

TERN Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
07 February 2025
TERN (-0.36%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 February 2025
TERN (-0.36%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 February 2025
TERN (-0.36%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 February 2025
TERN (-0.36%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 January 2025
TERN (-0.36%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.185-4.243119266064.364.364.00511246734.11296454CS
4-0.435-9.436008676794.614.7654.00518075394.41493688CS
12-2.205-34.56112852666.387.464.00518385745.38488817CS
26-3.865-48.07213930358.0411.44.00518875137.13220659CS
52-3.655-46.67943805877.8311.44.00514832017.09669266CS
1560.1553.855721393034.0214.04351.457773917.10553352CS
260-12.775-75.368731563416.9528.361.456000517.45579283CS

TERN - Frequently Asked Questions (FAQ)

What is the current Terns Pharmaceuticals share price?
The current share price of Terns Pharmaceuticals is US$ 4.175
How many Terns Pharmaceuticals shares are in issue?
Terns Pharmaceuticals has 84,938,855 shares in issue
What is the market cap of Terns Pharmaceuticals?
The market capitalisation of Terns Pharmaceuticals is USD 355.89M
What is the 1 year trading range for Terns Pharmaceuticals share price?
Terns Pharmaceuticals has traded in the range of US$ 4.005 to US$ 11.40 during the past year
What is the PE ratio of Terns Pharmaceuticals?
The price to earnings ratio of Terns Pharmaceuticals is -3.93
What is the reporting currency for Terns Pharmaceuticals?
Terns Pharmaceuticals reports financial results in USD
What is the latest annual profit for Terns Pharmaceuticals?
The latest annual profit of Terns Pharmaceuticals is USD -90.21M
What is the registered address of Terns Pharmaceuticals?
The registered address for Terns Pharmaceuticals is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Terns Pharmaceuticals website address?
The website address for Terns Pharmaceuticals is www.ternspharma.com
Which industry sector does Terns Pharmaceuticals operate in?
Terns Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MNDRMobile health Network Solutions
US$ 0.7199
(118.62%)
386.33M
XOSXos Inc
US$ 6.19
(97.76%)
92.24M
AGHAureus Greenway Holdings Inc
US$ 6.10
(58.03%)
2.04M
FGENFibroGen Inc
US$ 0.830098
(47.70%)
114.04M
REBNReborn Coffee Inc
US$ 7.82
(39.89%)
7M
WOKWORK Medical Technology Group Ltd
US$ 1.17
(-53.01%)
107.15M
MTLSMaterialise NV
US$ 5.85
(-36.55%)
2.18M
EDITEditas Medicine Inc
US$ 2.1601
(-32.50%)
11.07M
JTAIJet AI Inc
US$ 7.1399
(-29.66%)
6.87M
MULNMullen Automotive Inc
US$ 5.1249
(-28.32%)
1.08M
MNDRMobile health Network Solutions
US$ 0.7199
(118.62%)
385.21M
PLTRPalantir Technologies Inc
US$ 105.13
(-6.18%)
193.2M
ADTXAditxt Inc
US$ 0.1167
(-9.25%)
184.73M
APTOAptose Biosciences Inc
US$ 0.1872
(24.88%)
159.54M
SMCISuper Micro Computer Inc
US$ 59.90
(-0.58%)
154.16M

Discussion

View Full Feed
JSmith5 JSmith5 2 minutes ago
The negotiations with Denmark have gone extremely well

Hey Fully Diluted - As long he can put a golf course on it could work. If it were me, I would try to swap it with Denmark for a Blue state and maybe throw in a couple of ex VPs. Also, the promise of an NFL expansion franchise ma
FNMA
stockplayer-11 stockplayer-11 2 minutes ago
NUGN 0012 took some there.
Beaten down chart
NUGN
Mr. Williams1 Mr. Williams1 2 minutes ago
Well, like you guys, I got screwed and now after all these years, Jim Nixon isn't talking to me either. (And I only live a few blocks from him). This is truly the end of my association with Jim, and he is ducking my phone calls.

Here's his phone number. Maybe you guys will have b
Bobk101 Bobk101 2 minutes ago
LOL, I never hold more than 100.00 of this POS Scam
If they actually wanted to really do anything, they would have in the last 20 years being public.
Same scam, over and over, just different stories and lies lol
Pick any date on here in the past... all the same stuff
GMPR
pinkslipjunkie pinkslipjunkie 2 minutes ago
Pretty good volume too...interesting for sure...I have also noticed that EMGE has been picking up a little volume and getting some pretty good hits here as well...yesterday 1 million hit between .001 and .011
EMGE
Lime Time Lime Time 3 minutes ago
.0015 bid
.0018 ask
RSPI
oniro3363 oniro3363 3 minutes ago
109.00...concrete ceiling... Hope we bust through soon
COOP
TightCoil TightCoil 3 minutes ago
Not for Sale?
You is Skeerin' me
FNMA
gp22 gp22 3 minutes ago
Found another great Immune play after making huge gains in $IOVA.
$ESLA @ $1.40s: Low floater just got a one year price target of $16 from highly regarded bio/pharma Boral Capital...Volume precedes price...Looking great.
https://finance.yahoo.com/news/estrella-immunopharma-inc-nasdaq-e
ESLA IOVA
BLULLISH BLULLISH 3 minutes ago
SHORT SQUEEZE WILL COME SOON AND CRUSH SHORT POSITION BASHERS AHAHAHAHAHA

$GO $SINC
GO SINC
Jack-Squatt Jack-Squatt 3 minutes ago
The word “anyway” does not have an “s” at the end of it. As a trillionairre investor in nsav i just thought you would like to know that.
NSAV
AtlasQ AtlasQ 4 minutes ago
I asked my friend CHAT
Here’s a brief comparison of the medical regulatory agencies between the USA (FDA) and India (CDSCO) in terms of their strictness, regulatory framework, and enforcement:

USA: Food and Drug Administration (FDA)
Regulatory Body: The FDA (Food and Dr
RDGL
capgain capgain 4 minutes ago
That's a cool site! Thanks.
BlazingStocks BlazingStocks 4 minutes ago
$COEP - The innovative ValuSocial platform is set to transform the landscape of digital marketing by offering users a fully immersive environment where they can leverage NexGenAI's pioneering solutions. This integration will empower individuals and businesses to launch targeted digital campaigns tha
COEP
Louie_Louie Louie_Louie 4 minutes ago
Patel is confirmed! Now the major players are in place. Pulte's confirmation, I believe, will be expedited. PAtel will start working with Musk and Bondi in following the money...Then there's those Obama docs which really need to be let lose, will they do it though? I have a really bad feeling th
Lone Clone Lone Clone 4 minutes ago
Kingfisher Continues to Expand its Consolidated HWY 37 Project in the Golden Triangle with the Closing of the Hickman Project Acquisition

https://www.accessnewswire.com/newsroom/en/metals-and-mining/kingfisher-continues-to-expand-its-consolidated-hwy-37-project-in-the-golden-trian-988
JusticeWillWin JusticeWillWin 4 minutes ago
COOP daily chart======>ASCENDING CHANNEL

https://www.tradingview.com/x/zRcZvZqc/
COOP
exwannabe exwannabe 4 minutes ago
More of the same. this time it is a report on FOX about vaccine treatments for breast cancer that are coming out of PI and may enter PII. But still no notice or peep about DCVAX-L that has completed PIII and is days away from receiving approval (MAA) from the UK. I truly believe that the media are r
NWBO PII PIII
OINGO BOINGO OINGO BOINGO 4 minutes ago
Imo when dealing with these otc companies most of the time management comes 1st and shareholders last. They could care less if the sp takes a beating and shareholder value is destroyed otherwise we wouldn't be in the predicament we are in. Bottom line is if all the dd that's been put out there by
AFFU
ThoughtPower ThoughtPower 5 minutes ago
Are you really this miserable and pathetic?
CEOS
NitroFarmer NitroFarmer 5 minutes ago
Don’t worry,Pits. If this goes to zero, I’ll give you two dollars for your 23 shares and a complementary tube of Vagisil
LWLG
samson8 samson8 5 minutes ago
LMAO whats even the point?
GMZP

Your Recent History

NASDAQ
TERN
Terns Pharmaceuticals
BOV
SPTW11
Sp Downtown Fundo Invest...
BIT
UB7RXT
Unicredit Bank
BIT
UB3CVZ
Unicredit Bank
BIT
F37669
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads